Comparison

JQ1

Item no. RPE-CV-1007-1
Manufacturer rPeptide
Amount 5.0 mg
Quantity options 5.0 mg 25.0 mg
Category
Type Inhibitors
Format Solid
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Room temperature
Available
Manufacturer - Category
COVID-19/ Small Molecules
Shipping Temperature
Ambient
Storage Conditions
-20°C
Description
JQ1 is a potent BET bromodomain inhibitor. IC50 = 17.7, 32.6, 76.9 and 12942 nM respectively for BRD2 (N-terminal (N)), BRD4 (C-terminal (C)), BRD4 (N) and CREBBP respectively (data for + isomer). Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models. Induces squamous differentiation in NMC cell lines and inhibits tumor growth in NMC xenografts. Blocks inflammation and bone loss in periodontitis. Displays reversible contraceptive effects in male mice. Note this product is racemic (+/-) making the IC50 nominally 2 fold greater than literature values for the (+) isomer (offered as a lower cost option).
Physical State
White powder

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5.0 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close